Miti Biosystems


Miti Biosystems will establish strategic partnerships with Pharma & Biotech once our RiPP platform technology is fully validated. By combining the proven advantages of phage display of peptides with the unique action of PTM enzymes, Miti aims to generate developable leads for our partners with superior drug-like properties.

If you are interested in additional information please contact:
Dr. Guntram Christiansen -